We are live on
!
Find out more
HF
HRT Financial Portfolio holdings
AUM
$40.1B
1-Year Est. Return
58.22%
This Fund
S&P 500
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.8%
AUM
$40.1B
AUM Growth
+$8.37B
(+26%)
Cap. Flow
+$13B
Cap. Flow
% of AUM
32.41%
Top 10 Holdings %
Top 10 Hldgs %
27.27%
Holding
5,081
New
1,977
Increased
1,066
Reduced
622
Closed
1,387
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$621M |
| 2 |
SNDK
Sandisk
SNDK
|
+$467M |
| 3 |
AbbVie
ABBV
|
+$205M |
| 4 |
Valero Energy
VLO
|
+$150M |
| 5 |
SoFi Technologies
SOFI
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$599M |
| 2 |
NVIDIA
NVDA
|
+$468M |
| 3 |
Applied Materials
AMAT
|
+$306M |
| 4 |
Apple
AAPL
|
+$280M |
| 5 |
Micron Technology
MU
|
+$260M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.83% |
| 2 | Financials | 6.27% |
| 3 | Industrials | 4.73% |
| 4 | Healthcare | 4.21% |
| 5 | Energy | 4.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Hub Cyber Security
HUBC
$6.27M
| $14K | ﹤0.01% |
146
+141
| +2,820% | +$333K |
|
3602
IceCure Medical
ICCM
$9.87M
| $14K | ﹤0.01% |
1,587
+1,075
| +210% | +$19.6K |
|
3603
InflaRx
IFRX
$250M
| $14K | ﹤0.01% |
15,997
-31,489
| -66% | -$29.7K |
|
3604
Lexaria Bioscience
LEXX
$12.9M
| $14K | ﹤0.01% |
+18,465
| New | +$13.4K |
|
3605
Pliant Therapeutics
PLRX
$66.9M
| $14K | ﹤0.01% |
11,196
-21,009
| -65% | -$26.5K |
|
3606
Talphera
TLPH
$65.4M
| $14K | ﹤0.01% |
+19,090
| New | +$17.3K |
|
3607
VistaGen Therapeutics
VTGN
$9.45M
| $14K | ﹤0.01% |
25,370
-12,215
| -32% | -$7.42K |
|
3608
Metagenomi Therapeutics
MGX
$45.6M
| $14K | ﹤0.01% |
10,674
-417
| -4% | -$648 |
|
|
BGM
3609
BGM Group Ltd
BGM
$114M
| $14K | ﹤0.01% |
+48,174
| New | +$92K |
|
|
HYFT
3610
MindWalk Holdings
HYFT
$67.3M
| $13K | ﹤0.01% |
12,135
+1,364
| +13% | +$2.17K |
|
|
MRM
3611
MEDIROM Healthcare Technologies
MRM
$7.82M
| $13K | ﹤0.01% |
+11,905
| New | +$17.3K |
|
3612
Outlook Therapeutics
OTLK
$198M
| $13K | ﹤0.01% |
+67,759
| New | +$29.3K |
|
|
RVPH
3613
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $13K | ﹤0.01% |
18,423
+16,867
| +1,084% | +$76.7K |
|
3614
Worksport
WKSP
$9.4M
| $13K | ﹤0.01% |
12,948
+852
| +7% | +$1.41K |
|
|
DYORW
3615
Insight Digital Partners II Warrants
DYORW
$2.19M
| $13K | ﹤0.01% |
+48,986
| New | +$15.6K |
|
|
OPENL
3616
Opendoor Technologies Inc Series A Warrants
OPENL
$5.96M
| $13K | ﹤0.01% |
+53,631
| New | +$26K |
|
3617
Blink Charging
BLNK
$79.5M
| $12K | ﹤0.01% |
+22,793
| New | +$16.1K |
|
3618
Fate Therapeutics
FATE
$283M
| $12K | ﹤0.01% |
10,398
-38,146
| -79% | -$46.4K |
|
3619
Rafael Holdings
RFL
$119M
| $12K | ﹤0.01% |
10,278
-18,004
| -64% | -$22.9K |
|
3620
Senti Biosciences Holdings
SNTI
$11.6M
| $12K | ﹤0.01% |
+14,844
| New | +$14.4K |
|
|
KAPA
3621
Kairos Pharma
KAPA
$6.63M
| $12K | ﹤0.01% |
21,575
+256
| +1% | +$171 |
|
|
LBGJ
3622
Li Bang International
LBGJ
$93K
| $12K | ﹤0.01% |
+12,239
| New | +$633K |
|
|
IPST
3623
IP Strategy Holdings
IPST
$1.72M
| $12K | ﹤0.01% |
+2,431
| New | +$44.7K |
|
|
SLMT
3624
Brera Holdings
SLMT
$44.6M
| $11K | ﹤0.01% |
1,530
-5,659
| -79% | -$74.5K |
|
3625
Femasys
FEMY
$9.24M
| $11K | ﹤0.01% |
1,337
-1,305
| -49% | -$14.5K |
|
Similar funds
HRT Financial's Q1 2026 Portfolio in Review
As of Q1 2026, HRT Financial held 5,081 positions worth $40.1B, up 26% from $31.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
HRT Financial deployed $13B of net new capital in Q1 2026, opening 1,977 new positions and adding to 1,066 existing holdings. Its largest new stake was AbbVie: 926,410 shares worth $201M.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 15% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Broadcom, an estimated $599M trimmed.
- HRT Financial's largest Q1 2026 buy was AbbVie: 926,410 shares worth $201M.
- HRT Financial added most to Invesco QQQ Trust in Q1 2026, an estimated $621M increase.
- HRT Financial's biggest Q1 2026 reduction was Broadcom, cutting an estimated $599M.
- HRT Financial fully exited NVIDIA in Q1 2026, selling an estimated $468M.
- HRT Financial's ten largest holdings make up 27% of its $40.1B portfolio in Q1 2026.
- HRT Financial opened 1,977 new positions and closed 1,387 in Q1 2026.
- HRT Financial's portfolio value rose 26% quarter-over-quarter to $40.1B.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.